International Flavors & Fragrances IFF Health & Biosciences — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's health & biosciences — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is International Flavors & Fragrances's health & biosciences — goodwill?
- International Flavors & Fragrances (IFF) reported health & biosciences — goodwill of $4.44B in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — goodwill changed year-over-year?
- International Flavors & Fragrances's health & biosciences — goodwill increased by 2.3% year-over-year, from $4.34B to $4.44B.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — goodwill?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's health & biosciences — goodwill has grown at a -12.0% compound annual growth rate (CAGR), from $29.62B to $17.73B.
- What does health & biosciences — goodwill mean?
- The intangible asset value representing the premium paid for acquisitions within the Health & Biosciences segment over the fair value of net identifiable assets. It reflects the value of brand reputation, customer relationships, and proprietary technology.